Contract Pharmaceuticals Limited Canada recalls Clindamycin Phosphate
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.
- Products
-
- Clindamycin Phosphate
- Where it was sold
-
Nationwide in the U.S. and Puerto Rico
Nationwide
- Units affected
- 45,875 bottles
- About this recall
- Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61